medigraphic.com
ISSN 1561-302X (Print)

2021, Number 1

<< Back Next >>

Rev cubana med 2021; 60 (1)

Disseminated amelanotic melanoma

Valdés AK, Felipe JA, Chao PC

Language: Spanish
References: 11
Page: 1-7
PDF size: 447.47 Kb.


ABSTRACT

Amelanotic melanoma is one of the neoplasms with the highest mortality rate because it is highly aggressive and the diagnostic probability is low. It affects the population of the entire globe, more frequent in Caucasians, with genetic predisposition and risk factors such as sun exposure. It presents survival rates of less than 10% at 5 years and high recurrence rates; with evidence of distant metastatic processes in organs such as brain, subcutaneous cellular tissue, lung, peritoneum, bone, which casts a shadow on the prognosis. We report the case of a 21-year-old patient who came to the hospital due to ecchymotic lesions, subcutaneous nodules and a two-month evolution of left hemicrania headache. She underwent chest and abdomen tomography and MRI of the skull. They showed metastatic spread. Histopathological study was performed with immunohistochemistry that reported amelanotic melanoma.


REFERENCES

  1. Seigel RL, Miller KD. A cáncer estatistics, 2015. CA Cancer J Clin. 2019[acceso: 01/02/2020],69(1):7-34. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/30620402

  2. Lucas R, McMichael T, Smith W, Armstrong B. Solar ultraviolet radiation: Global burden of disease from solar ultraviolet radiation. Ginebra: OMS; 2006[acceso: 14/02/2019]. (Environmental Burden of Disease Series No. 13). Disponible en: https://apps.who.int/iris/handle/10665/43505

  3. Kraft Rovere R, Pires ME. Melanoma patterns of distant relapse: a study of 108 cases from a South Brazilian center. An Bras Dermatol. 2016[acceso: 14/02/2019];91(1):40-3. Disponible: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782645/

  4. Thapa S, Ghosh A, Ghartimagar D, Prasad T, Narasimhan R, Talwar O, et al. Clinicopathological study of malignant melanoma at tertiary care centre. JNMA J Nepal Med Assoc. 2017;56:132-6.

  5. Leachman SA, Cassidy PB, Chen SC. Methods of melanoma detection Cáncer Treat Res. 2016;167:51-105.

  6. Muinonen-Martin AJ, O’Shea SJ, Newton-Bishop J. Amelanotic melanoma. BMJ. 2018;360:k826. http://doi.org/10.1136/bmj.k826

  7. Kaizer-salk KA, Herten RJ, Ragsdale BD, Sengelmann RD. Amelanotic melanoma: a unique case study and review of the literatura. BMJ Case Rep. 2018. http://doi.org/10.1136/bcr-2017-22275

  8. Reed D, Kudchadkar R, Zager js Sondak VK, Messina JL. Controversies un the evaluation and management of atypical melanocytic proliferation in children adolescents, and Young adults. J Natl Compr Cáncer Netw. 2013[acceso: 14/02/2019];11:679-86. Disponible: https://www.ncbi.nlm.nih.gov/pubmed/23744867

  9. Goodson AG, Grossman D. Strategies for early melanoma detection: Approaches to the patient whit nevi. Journal American Academy Dermatology. 2009[acceso: 14/02/2019];60:719-35. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19389517

  10. Goodson AG, Grossman D. Strategies for early melanoma detection: Approaches to the patient whit nevi. Journal American Academy Dermatology. 2009[acceso: 14/02/2019];60:719-35. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/19389517

  11. Infante MC, González MA, Jaén L, del Valle S. Melanoma cutáneo: algunas consideraciones actuales. MEDISAN. 2019[acceso: 14/02/2019];23(1)146. Disponible en: http://www.medisan.sld.cu/index.php/san/article/view/2409




2020     |     www.medigraphic.com